List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Prothrombin Complex Revenue
1.4 Market Analysis by Type
1.4.1 Global Human Prothrombin Complex Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 500 IU/Vial
1.4.3 600 IU/Vial
1.4.4 1000 IU/Vial
1.5 Market by Application
1.5.1 Global Human Prothrombin Complex Market Share by Application: 2022-2027
1.5.2 Hemophilia B
1.5.3 Vitamin K Deficiency
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Human Prothrombin Complex Market
1.8.1 Global Human Prothrombin Complex Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Human Prothrombin Complex Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Human Prothrombin Complex Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Human Prothrombin Complex Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Human Prothrombin Complex Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Human Prothrombin Complex Sales Volume Market Share by Region (2016-2021)
3.2 Global Human Prothrombin Complex Sales Revenue Market Share by Region (2016-2021)
3.3 North America Human Prothrombin Complex Sales Volume
3.3.1 North America Human Prothrombin Complex Sales Volume Growth Rate (2016-2021)
3.3.2 North America Human Prothrombin Complex Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Human Prothrombin Complex Sales Volume
3.4.1 East Asia Human Prothrombin Complex Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Human Prothrombin Complex Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Human Prothrombin Complex Sales Volume (2016-2021)
3.5.1 Europe Human Prothrombin Complex Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Human Prothrombin Complex Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Human Prothrombin Complex Sales Volume (2016-2021)
3.6.1 South Asia Human Prothrombin Complex Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Human Prothrombin Complex Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Human Prothrombin Complex Sales Volume (2016-2021)
3.7.1 Southeast Asia Human Prothrombin Complex Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Human Prothrombin Complex Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Human Prothrombin Complex Sales Volume (2016-2021)
3.8.1 Middle East Human Prothrombin Complex Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Human Prothrombin Complex Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Human Prothrombin Complex Sales Volume (2016-2021)
3.9.1 Africa Human Prothrombin Complex Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Human Prothrombin Complex Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Human Prothrombin Complex Sales Volume (2016-2021)
3.10.1 Oceania Human Prothrombin Complex Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Human Prothrombin Complex Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Human Prothrombin Complex Sales Volume (2016-2021)
3.11.1 South America Human Prothrombin Complex Sales Volume Growth Rate (2016-2021)
3.11.2 South America Human Prothrombin Complex Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Human Prothrombin Complex Sales Volume (2016-2021)
3.12.1 Rest of the World Human Prothrombin Complex Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Human Prothrombin Complex Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Human Prothrombin Complex Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Human Prothrombin Complex Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Human Prothrombin Complex Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Human Prothrombin Complex Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Human Prothrombin Complex Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Human Prothrombin Complex Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Human Prothrombin Complex Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Human Prothrombin Complex Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Human Prothrombin Complex Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Human Prothrombin Complex Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Human Prothrombin Complex Sales Volume Market Share by Type (2016-2021)
14.2 Global Human Prothrombin Complex Sales Revenue Market Share by Type (2016-2021)
14.3 Global Human Prothrombin Complex Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Human Prothrombin Complex Consumption Volume by Application (2016-2021)
15.2 Global Human Prothrombin Complex Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Human Prothrombin Complex Business
16.1 Shire
16.1.1 Shire Company Profile
16.1.2 Shire Human Prothrombin Complex Product Specification
16.1.3 Shire Human Prothrombin Complex Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 CSL
16.2.1 CSL Company Profile
16.2.2 CSL Human Prothrombin Complex Product Specification
16.2.3 CSL Human Prothrombin Complex Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Grifols
16.3.1 Grifols Company Profile
16.3.2 Grifols Human Prothrombin Complex Product Specification
16.3.3 Grifols Human Prothrombin Complex Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Octapharma
16.4.1 Octapharma Company Profile
16.4.2 Octapharma Human Prothrombin Complex Product Specification
16.4.3 Octapharma Human Prothrombin Complex Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Hualan Biological
16.5.1 Hualan Biological Company Profile
16.5.2 Hualan Biological Human Prothrombin Complex Product Specification
16.5.3 Hualan Biological Human Prothrombin Complex Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Meheco Xinxing Pharma
16.6.1 Meheco Xinxing Pharma Company Profile
16.6.2 Meheco Xinxing Pharma Human Prothrombin Complex Product Specification
16.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Human Prothrombin Complex Manufacturing Cost Analysis
17.1 Human Prothrombin Complex Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Human Prothrombin Complex
17.4 Human Prothrombin Complex Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Human Prothrombin Complex Distributors List
18.3 Human Prothrombin Complex Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Human Prothrombin Complex (2022-2027)
20.2 Global Forecasted Revenue of Human Prothrombin Complex (2022-2027)
20.3 Global Forecasted Price of Human Prothrombin Complex (2016-2027)
20.4 Global Forecasted Production of Human Prothrombin Complex by Region (2022-2027)
20.4.1 North America Human Prothrombin Complex Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Human Prothrombin Complex Production, Revenue Forecast (2022-2027)
20.4.3 Europe Human Prothrombin Complex Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Human Prothrombin Complex Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Human Prothrombin Complex Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Human Prothrombin Complex Production, Revenue Forecast (2022-2027)
20.4.7 Africa Human Prothrombin Complex Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Human Prothrombin Complex Production, Revenue Forecast (2022-2027)
20.4.9 South America Human Prothrombin Complex Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Human Prothrombin Complex Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Human Prothrombin Complex by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Human Prothrombin Complex by Country
21.2 East Asia Market Forecasted Consumption of Human Prothrombin Complex by Country
21.3 Europe Market Forecasted Consumption of Human Prothrombin Complex by Countriy
21.4 South Asia Forecasted Consumption of Human Prothrombin Complex by Country
21.5 Southeast Asia Forecasted Consumption of Human Prothrombin Complex by Country
21.6 Middle East Forecasted Consumption of Human Prothrombin Complex by Country
21.7 Africa Forecasted Consumption of Human Prothrombin Complex by Country
21.8 Oceania Forecasted Consumption of Human Prothrombin Complex by Country
21.9 South America Forecasted Consumption of Human Prothrombin Complex by Country
21.10 Rest of the world Forecasted Consumption of Human Prothrombin Complex by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
